Hodgkin Lymphoma News and Research

RSS

Zevalin highly effective in first-line treatment of low-grade follicular lymphoma

Results from a clinical trial presented at the American Society of Hematology 46th Annual Meeting and Exposition (ASH) demonstrated that Zevalin (ibritumomab tiuxetan), administered as a first-line therapy, induced a 100 percent response rate in a small population of patients with low-grate follicular lymphoma (FL).

6 Dec 2004

Bcl-6 oncogene - genetic target for lymphoma treatment

Results from a pre-clinical study show that the gene designated Bcl-6 is an oncogene -- that is, one with the potential to cause a normal cell to become cancerous -- but that certain peptide inhibitors can in effect inactivate it, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

5 Dec 2004

Genasense shown to enhance the anti-lymphoma activity of Velcade and Rituxan

Genta Incorporated announced that two new studies have shown that Genasense (oblimersen sodium) Injection, the Company's lead anticancer drug, showed synergistic activity with both bortezomib (Velcade; Millennium Pharmaceuticals, Inc.) and rituximab (Rituxan; Genentech, Idec) in experimental models of B-cell non-Hodgkin's lymphoma (NHL).

5 Dec 2004

Single dose phase I data on CG53135 for the prevention of oral mucositis

CuraGen Corporation has announced results presented from a Phase I clinical trial with CG53135 for the prevention of oral mucositis (OM) in patients receiving high dose chemotherapy (HDCT) followed by autologous hematopoietic stem cell transplantation (AHSCT) at the ASH 46th Annual Meeting in San Diego, CA.

5 Dec 2004

Scientists join forces to improve the effectiveness of a drug used to treat chronic myeloid leukaemia

Scientists from Glasgow and Liverpool are joining forces to improve the effectiveness of a drug used to treat a form of leukaemia, chronic myeloid leukaemia (CML), which affects 750 people in the UK each year.

24 Nov 2004

Understanding the signals that delay the spread of follicular lymphoma could provide new therapeutic targets

Scientists at the National Cancer Institute (NCI), have created a model that predicts the survival of follicular lymphoma patients based on the molecular characteristics of their tumors at diagnosis.

18 Nov 2004

Some allergic conditions could increase your risk of suffering from blood cancer

Some allergic conditions could increase your risk of suffering from blood cancer as an adult, according to a new study published in the November 2004 issue of BMC Public Health. This is important news for the increasingly large numbers of allergy sufferers worldwide.

4 Nov 2004

Presentation of the most recent and advanced work in the rapidly progressing field of fertility preservation

Each year approximately 50,000 women under the age of 40 are diagnosed with breast cancer. Treatments vary but most involve the administration of chemotherapeutic agents or radiation which can disrupt ovarian function or damage a patient’s eggs.

18 Oct 2004

People with diabetes mellitus have three to four times the risk of developing liver cancer

People with diabetes mellitus have three to four times the risk of developing liver cancer, and more than twice the risk of developing pancreatic cancer than non-diabetic individuals, according to research presented at the Third Annual Frontiers in Cancer Prevention Research Meeting in Seattle.

18 Oct 2004

Hepatitis C infection increases likelihood of developing non-Hodgkin's lymphoma significantly

Patients infected with the hepatitis C virus (HCV) are six times as likely to develop non-Hodgkin's lymphoma (NHL) than individuals that are virus free, according to research presented at the Third Annual Frontiers in Cancer Prevention Research meeting.

18 Oct 2004

Aspirin might well be considered the top utility player in the medicine cabinet

This cheap over-the-counter drug can be used not only for fever, pain and arthritis, but to prevent heart attack, stroke or angina. It also may reduce the risk of colorectal cancer. Yet aspirin also has side effects worth considering, and its very accessibility may hamper its use.

8 Oct 2004

University of Rochester Medical Center doctors are trying to improve childhood cancer treatments

University of Rochester Medical Center doctors are trying to improve childhood cancer treatments so that kids are less likely to develop heart problems or second malignancies later, as a result of radiation therapy.

6 Oct 2004

32-year-old woman has given birth to a healthy baby 7 years after banking her ovarian tissue before starting chemotherapy

Although she became infertile as a result of the chemotherapy, re-implantation of her ovarian tissue re-started ovulation 5 months later; she became pregnant 11 months after re-transplantation by natural fertilization. Details of the procedure appear in a research article published online by THE LANCET.

23 Sep 2004

Half of patients with aggressive non-Hodgkin's lymphoma fail to receive the recommended dose and schedule of chemotherapy

Approximately half of patients with aggressive non-Hodgkin's lymphoma (NHL) fail to receive the recommended dose and schedule of chemotherapy, reducing their chances for remission or cure.

20 Sep 2004

Health problems among timber workers exposed to industry chemical PCP are to be investigated

The project, funded by the Ministry of Health, aims to ascertain whether timber workers exposed to the PCPs (pentachlorophenols) are dying earlier, getting cancers more often and suffering more chronic health problems, including fatigue, nausea and neuropsychological dysfunction.

13 Sep 2004

Exposure to simian virus 40 (SV40) is not associated with cancer in humans

Two upcoming studies by scientists at the National Cancer Institute (NCI), provide further evidence that exposure to simian virus 40 (SV40) is not associated with cancer in humans.

23 Aug 2004

Cell Therapeutics receives Fast Track Designation for Pixantrone, treatment for aggressive non-Hodgkin's lymphoma

Cell Therapeutics, Inc. has received fast track designation from the U.S. Food and Drug Administration (FDA) for pixantrone, a novel anthracenedione, being investigated for the potential treatment of relapsed, aggressive non-Hodgkin's lymphoma (NHL).

12 Jul 2004

Understanding the role of c-Jun in repairing damaged nerve cells could help treat spinal injuries and increase our understanding of cancer

Research into the action of a key cancer gene has serendipitously uncovered its vital role in nerve growth, Cancer Research UK scientists reveal in a paper published on Wednesday.

8 Jul 2004

Omega-3's - fatty acids, can be produced in bioengineered plants

Long-chain omega-3 polyunsaturated fatty acids (n-3 LC-PUFAs) have benefits regarding cardiovascular and inflammatory function, certain types of cancer, and maternal and infant health, according to recent peer-reviewed studies.

2 Jul 2004

Successes in frozen ovarian tissue technology may offer hope to women being treated for cancer

Doctors in Denmark have succeeded in producing a two-cell embryo after ovarian tissue was removed, frozen, and then thawed and replaced two years later.

29 Jun 2004

Hodgkin Lymphoma News and Research

Zevalin highly effective in first-line treatment of low-grade follicular lymphoma

Bcl-6 oncogene - genetic target for lymphoma treatment

Genasense shown to enhance the anti-lymphoma activity of Velcade and Rituxan

Single dose phase I data on CG53135 for the prevention of oral mucositis

Scientists join forces to improve the effectiveness of a drug used to treat chronic myeloid leukaemia

Understanding the signals that delay the spread of follicular lymphoma could provide new therapeutic targets

Some allergic conditions could increase your risk of suffering from blood cancer

Presentation of the most recent and advanced work in the rapidly progressing field of fertility preservation

People with diabetes mellitus have three to four times the risk of developing liver cancer

Hepatitis C infection increases likelihood of developing non-Hodgkin's lymphoma significantly

Aspirin might well be considered the top utility player in the medicine cabinet

University of Rochester Medical Center doctors are trying to improve childhood cancer treatments

32-year-old woman has given birth to a healthy baby 7 years after banking her ovarian tissue before starting chemotherapy

Half of patients with aggressive non-Hodgkin's lymphoma fail to receive the recommended dose and schedule of chemotherapy

Health problems among timber workers exposed to industry chemical PCP are to be investigated

Exposure to simian virus 40 (SV40) is not associated with cancer in humans

Cell Therapeutics receives Fast Track Designation for Pixantrone, treatment for aggressive non-Hodgkin's lymphoma

Understanding the role of c-Jun in repairing damaged nerve cells could help treat spinal injuries and increase our understanding of cancer

Omega-3's - fatty acids, can be produced in bioengineered plants

Successes in frozen ovarian tissue technology may offer hope to women being treated for cancer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News